Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Verified Market Research | PRODUCT CODE: 1736637

Cover Image

PUBLISHER: Verified Market Research | PRODUCT CODE: 1736637

Global Cardiac Imaging Software Market Size By Imaging Modalities, By End-User, By Application, By Geographic Scope And Forecast

PUBLISHED:
PAGES: 202 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 3950
PDF & Excel (5 User License)
USD 4850
PDF & Excel (Enterprise User License)
USD 7550

Add to Cart

Cardiac Imaging Software Market Size And Forecast

Cardiac Imaging Software Market size was valued at USD 504.13 Million in 2024 and is projected to reach USD 906.81 Million by 2032, growing at a CAGR of 8.40% from 2026 to 2032.

The global Cardiac Imaging Software Market is predicted to develop due to technical improvements in imaging equipment, an older population, and an increase in heart procedures. The Global Cardiac Imaging Software Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Cardiac Imaging Software Market Size And Forecast

Cardiac Imaging Software Market size was valued at USD 504.13 Million in 2024 and is projected to reach USD 906.81 Million by 2032, growing at a CAGR of 8.40% from 2026 to 2032.

The global Cardiac Imaging Software Market is predicted to develop due to technical improvements in imaging equipment, an older population, and an increase in heart procedures. The Global Cardiac Imaging Software Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Cardiac Imaging Software Market Overview

The rising prevalence of cardiovascular diseases (CVD) is one of the primary reasons for hospitalization worldwide. According to WHO, CVDs are the leading cause of mortality worldwide, claiming an estimated 18 million lives each year. As a result of the increased frequency of cardiovascular disorders, there is a greater need for cardiac imaging software to identify heart-related issues using MRI, CT scan, angiography, radioactive chemicals, and other types of radiant light. Furthermore, factors such as an increase in the older population, technological improvements, and increased use of cardiac imaging modalities such as CT, PET, and others, a Rise in underlying causes of cardiovascular disease, and market participants' development plans of these factors are projected to benefit the worldwide Cardiac Imaging Software Market.

The high cost is mostly due to the high expense of contemporary technology, the extensive use of diagnostic tests, and pharmacological and medical therapies. In the United States, imaging expenses surpass USD 100 billion each year. Cardiovascular imaging (CVI) accounts for 29 percent of the total imaging burden and at least one-third of the several billion medical imaging exams conducted worldwide each year. Furthermore, this was ascribed in part to proprietary software products and their built-in interoperability with other software and hardware providers. Furthermore, there is a lack of uniformity across providers. This makes multi-site, population-based research challenging to conduct, as data may be acquired from gear produced by various suppliers. This is projected to slow the global Cardiac Imaging Software Market's growth.

Global Cardiac Imaging Software Market Segmentation Analysis

The Global Cardiac Imaging Software Market is Segmented on the basis of Imaging Modalities, End-User, Application, and Geography.

Cardiac Imaging Software Market, By Imaging Modalities

  • Computed Tomography
  • Magnetic Resonance
  • Ultrasound Imaging
  • X-Ray Imaging
  • Combined Modalities

Based on Imaging Modalities, the market is segmented into Computed Tomography, Magnetic Resonance, Ultrasound Imaging, X-Ray Imaging, and Combined Modalities. The computed tomography sector is predicted to increase at a healthy rate over the projection period because it is more efficient than conventional X-rays at delivering doses of cancer-damaging radiation.

Cardiac Imaging Software Market, By End-User

  • Hospital & Clinics
  • Diagnostic Centers
  • Others

Based on End-User, the market is segmented into Hospitals & Clinics, Diagnostic Centers, and Others. The market has seen a dramatic surge in the number of patients suffering from cardiovascular illnesses such as coronary heart disease, heart attacks, strokes, congenital heart disease, and others during the previous few years. The number of hospitals worldwide is steadily rising as the number of patients increases. By end-user, hospitals and clinics dominate the worldwide Cardiac Imaging Software Market. This share is mostly due to an increase in the number of individuals being monitored for a heart condition.

Cardiac Imaging Software Market, By Application

  • Diagnostic Imaging
  • Image Guided Treatment
  • Patient Monitoring

Based on Application, the market is segmented into Diagnostic Imaging, Image Guided, and Patient Monitoring.

Cardiac Imaging Software Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Geography, the Global Cardiac Imaging Software Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America Americas accounted for the majority of the global market because of the high prevalence of cardiovascular diseases, technological advancements, high disposable income, a growing older population, and a favorable regulatory environment. The rise in the frequency of heart diseases is linked to North America's dominance.

Key Players

The "Global Cardiac Imaging Software Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as Shimadzu Corporation, Koninklijke Philips NV, Siemens AG, Canon Inc., Agfa-Gevaert Group, General Electric, Circle Cardiovascular, Fujifilm Holdings Corporation, Symphony Innovation, LLC, and Pie Medical Imaging.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Key Developments

  • In June 2021, Circle Cardiovascular Imaging Inc. (Canada) formed an alliance with DiA Imaging Analysis (Israel). This collaboration will provide clients with all-in-one complete Ai-based cardiovascular imaging solutions, as well as new potential in multi-modality imaging solutions for physicians, patients, and hospitals globally. Circle's cardiac imaging offering will be strengthened by DiA's FDA-cleared and CE-marked LVivo Toolbox, a series of breakthrough AI-based cardiac ultrasound products.
  • In June 2021, GE Healthcare (US) partnered with the American College of Cardiology (US) to develop artificial intelligence and digital health technology in cardiology.
  • In March 2021, TeraRecon, one of the top healthcare imaging AI technology businesses, has been acquired by Symphony Innovation, LLC (US). Symphony AI Group has begun its new range of healthcare AI solutions centered on medical imaging with this purchase.
Product Code: 38108

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL CARDIAC IMAGING SOFTWARE MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL CARDIAC IMAGING SOFTWARE MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL CARDIAC IMAGING SOFTWARE MARKET, BY IMAGING MODALITY

  • 5.1 Overview
  • 5.2 Computed Tomography
  • 5.3 Magnetic Resonance
  • 5.4 Ultrasound Imaging
  • 5.5 X-Ray Imaging
  • 5.6 Combined Modalities

6 GLOBAL CARDIAC IMAGING SOFTWARE MARKET, BY END-USER

  • 6.1 Overview
  • 6.2 Hospitals & Clinics
  • 6.3 Diagnostics Centers
  • 6.4 Others

7 GLOBAL CARDIAC IMAGING SOFTWARE MARKET, BY APPLICATION

  • 7.1 Overview
  • 7.2 Diagnostic Imaging
  • 7.3 Image Guided Treatment
  • 7.4 Patient Monitoring

8 GLOBAL CARDIAC IMAGING SOFTWARE MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East and Africa

9 GLOBAL CARDIAC IMAGING SOFTWARE MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 Shimadzu Corporation
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Koninklijke Philips NV
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 Siemens AG
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Canon Inc.
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 Agfa-Gevaert Group
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 General Electric
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 Circle Cardiovascular
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Fujifilm Holdings Corporation
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 Symphony Innovations, LLC
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments
  • 10.10 Pie Medical Imaging
    • 10.10.1 Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Outlook
    • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

  • 11.1 Product Launches/Developments
  • 11.2 Mergers and Acquisitions
  • 11.3 Business Expansions
  • 11.4 Partnerships and Collaborations

12 Appendix

  • 12.1 Related Research
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!